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The nature, 2,3 application 4 and compliance 5, 6 with dental infection control processes -including decontamination -are long-term 7 and ongoing areas of practice-related dental research. In addition, the scientific understanding of infection control has grown with theoretical or actual new risks emerging, 8 such as MRSA, HIV, TB and, latterly, the role of prion proteins in vCJD, 9, 10 although in practice the likelihood of infection transmission within the dental workplace is considered to be low.
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• Decontamination: processes including cleaning, disinfection, inspection and sterilisation to render reusable surgical instruments safe for further use.
• Epidemiological evidence: determination of causes, incidence and characteristic behaviour of disease outbreaks affecting human populations.
• Cross-infection related dental infections:
any infection which a patient contracts in a dental practice.
• Total cost: the healthcare impact cost of cases of cross-infection from dental practices.
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Since August 2009, members of the Primary Care Dentistry Research Forum (www.dentistryresearch.org) have taken part in an online vote to identify questions in day-to-day practice that they felt most needed to be answered with conclusive research. The question which receives the most votes each month forms the subject of a critical appraisal of the relevant literature. Each month a new round of voting takes place to decide which further questions will be reviewed. Dental practitioners and dental care professionals are encouraged to take part in the voting and submit their own questions to be included in the vote by joining the website. The paper below details a summary of the findings of the seventh critical appraisal. In conclusion, the critical appraisal identified no evidence on the epidemiological scale of cross-infection caused in dental practices and therefore also of the cost impact of cross-infection caused in primary dental practices. As a result, no 'cost of illness', or cost-benefit assessment, exists or is feasible at this time.
Primary dental care practices are now required to deliver quality decontamination processes 12, 13 and from 2011 to be regulated by the Care Quality Commission, 14 with baseline audit data presently being collected through the Dental National Decontamination Survey.
15,16
The survey does not appear to collect data on cross-infection incidence nor costs associated with respective aspects of guidance compliance. Consideration of the cost-benefit to primary dental practice for provision of the new decontamination processes 17, 18 invites assessment of the scale of the problem that dental decontamination processes aim to address, of the cost of undertaking these procedures to respond to the problem described, and of the benefits arising.
To address the review question, two sub-questions have been posed:
What epidemiological evidence is 1.
there about cross-infection related infections caused in dental practices? What is the total cost of cross-2.
infection related infections caused in dental practices?
REviEw METhod
An initial search was made of Ovid MEDLINE (1950 to week 5, March 2010) using the search terms decontamination/sterilisation; dentistry; dental economics; cost-benefit analysis; limited to 1999-2010; and UK. Five papers were identified and five were excluded. Further searches were then made of the NHS Economic Evaluation Database using the search terms cross-infection; infection control; infection and dental; contamination and instruments; and decontamination. Two potentially relevant titles were identified and retrieved as full papers. Two papers were then rejected. Additional searches included CEBD, Cochrane Oral Health Group, CRD, ADA, TRIP database, DARE. In addition, the Department of Health published evidence-graded references for HTM 01-05.
Further contact was then made with the British Dental Association and the National Patient Safety Agency, and was also initiated with the Department of Health Dental National Decontamination Survey team.
FindingS
In total, five titles and abstracts arising from the above searches were identified and two were retrieved as full text, then rejected.
what epidemiological evidence is there about cross-infection related infections caused within dental practices?
We could find no studies that described the incidence of cross-infection related infections caused within UK dental practices, including cross-infection arising from reusable dental surgical instruments.
On this basis, the scale of the problem that dental decontamination processes aim to address currently appears to be unknown.
While not answering the review question, in comparison, an estimate exists of hospital-acquired infections. This is approximately 9% of inpatients, including 273,000 non-fatal infections and 4,550 deaths per year. 19 Since 2007, in response, the UK government has undertaken a £57.5 million NHS hospital ward 'deep cleaning' programme. However, these data relate to the medical and hospital context, with uncertain applicability to the dental practice context.
what is the total cost of cross-infection related infections caused in dental practices?
In the absence of incidence data relating to cross-infections caused in UK primary dental practices, or on the severity (including disabilities or deaths arising) of such infections, it is not possible to estimate their cost impact. No studies were found to provide insight into the potential savings in terms of the number of dental practice related cross-infections avoided by compliance with infection control guidance. Only one study, which is both quite old and specific to Australian private dental practice, 20 attempted to quantify the costs of implementing recommended infection control procedures. This amounted to an annual amount of AU$22,461 per dentist plus AU$1,912 per practice (1994 $AUS), including loss of billable revenue, disposables, equipment, waste management and nurse time for sterilisation procedures.
SUMMARY
Although there is a literature upon the nature, implementation and adherence to generic dental infection control guidance and practice, there appears to be none, from the UK and beyond, on the epidemiological scale of cross-infection caused in dental practices and therefore also of the cost impact of cross-infection caused in primary dental practices. Consequently, no cost of illness or costbenefit assessment exists or is feasible at this time.
